Загрузка...
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
Although immune checkpoint blockade has shown initial success for various cancers, only a small subset of patients benefits from this therapy. Some chemotherapeutic drugs have been reported to induce antitumor T cell responses, prompting a number of clinical trials on combination chemoimmunotherapy....
Сохранить в:
| Опубликовано в: : | Sci Adv |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Association for the Advancement of Science
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5906077/ https://ncbi.nlm.nih.gov/pubmed/29675465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aao1736 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|